Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DECIPHER LABS   ACTAVIS
EQUITY SHARE DATA
    DECIPHER LABS
Mar-23
ACTAVIS
Dec-18
DECIPHER LABS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs6316,126-   
Low Rs1410,818-   
Sales per share (Unadj.) Rs45.13,955.8-  
Earnings per share (Unadj.) Rs-2.7-1,274.2-  
Cash flow per share (Unadj.) Rs-2.2416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs23.016,315.7-  
Shares outstanding (eoy) m10.10332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.93.4 25.1%   
Avg P/E ratio x-14.5-10.6 137.2%  
P/CF ratio (eoy) x-17.332.3 -53.4%  
Price / Book Value ratio x1.70.8 203.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m3894,480,758 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m4120-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m4561,315,689 0.0%  
Other income Rs m7425,160 0.3%   
Total revenues Rs m5291,340,849 0.0%   
Gross profit Rs m-10634,478 -0.3%  
Depreciation Rs m4562,428 0.0%   
Interest Rs m575,923 0.0%   
Profit before tax Rs m-42-578,713 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m-15-7,334 0.2%   
Profit after tax Rs m-27-423,784 0.0%  
Gross profit margin %-23.32.6 -889.3%  
Effective tax rate %35.51.3 2,802.3%   
Net profit margin %-5.9-32.2 18.3%  
BALANCE SHEET DATA
Current assets Rs m201539,627 0.0%   
Current liabilities Rs m50477,372 0.0%   
Net working cap to sales %33.24.7 701.5%  
Current ratio x4.11.1 358.5%  
Inventory Days Days3020 153.8%  
Debtors Days Days78966 1,190.3%  
Net fixed assets Rs m71148,929 0.0%   
Share capital Rs m1010-   
"Free" reserves Rs m1310-   
Net worth Rs m2325,426,601 0.0%   
Long term debt Rs m01,910,903 0.0%   
Total assets Rs m2728,483,012 0.0%  
Interest coverage x-7.6-6.6 115.2%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.70.2 1,081.9%   
Return on assets %-8.1-4.1 197.6%  
Return on equity %-11.6-7.8 148.0%  
Return on capital %-15.8-4.8 327.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-16470,046 -0.0%  
From Investments Rs m-43258,229 -0.0%  
From Financial Activity Rs m-22-806,740 0.0%  
Net Cashflow Rs m-80-78,073 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare DECIPHER LABS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DECIPHER LABS With: BIOCON   WYETH  SANJIVANI PA  AMRUTANJAN HEALTHCARE  DIVIS LABORATORIES  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.